1.
Inhibitor of Neutrophil Proteinases Elafin Expression in Pichia Pastoris and Activity Investigation;
中性粒细胞蛋白酶抑制剂elafin酵母工程菌构建及其生物活性研究
2.
Experimental Study of the Effect of NE in the Rat Intracerebral Hemorrhage(ICH) and the Protection of Sivelestat Sodium from the Rat ICH;
中性粒细胞弹性蛋白酶及其抑制剂对大鼠脑出血作用的实验研究
3.
Experimental Study of Effects of Neutrophil Elastase and Its Inhibitor on Focal Cerebral Ischemia-Reperfusion in Rats;
中性粒细胞弹性蛋白酶及其抑制剂对大鼠脑缺血/再灌注作用的实验研究
4.
Expression of the cell circle related kinase inhibitor p27kip1 in pterygium
细胞周期蛋白依赖性激酶抑制剂p27kip1在翼状胬肉中的表达
5.
The increased NK cell-mediated cytotoxicity in human hepatocellular carcinoma by low-dose proteasome inhibitor Bortezomib through NKG2D pathway
蛋白酶体抑制剂Bortezomib对NK细胞杀伤肝癌细胞活性的影响
6.
Inhibition on telomerase activity of HepG2 cells by antisense oligonucleotides of telomerase carried by albumin nanoparticles
白蛋白纳米载体介导的反义核酸对肝癌细胞端粒酶活性的抑制
7.
Mechanism of drug resistance for chronic myeloid leukemia to BCR-ABL tyrosine kinase inhibitor
慢性粒细胞白血病对BCR-ABL酪氨酸激酶靶向抑制剂的耐药机制
8.
Effect of Proteasome Inhibitors MG-132 at Different Doses on Cultured K562 Cell Apotosis
不同剂量蛋白酶体抑制剂MG-132在诱导K562细胞株凋亡中的作用
9.
Involved Mechanism of Proteasome Inhibitor Bortezomib-Mediated Acquired TRAIL Resensitization in Human Colon Cancer Cell;
蛋白酶体抑制剂bortezomib逆转结肠癌细胞获得性TRAIL耐药的机制研究
10.
Relation between cyclin dependent kinase inhibitor and tumors:recent progress
细胞周期蛋白依赖性激酶抑制剂与肿瘤相关性的研究进展
11.
Synergistic Effect of Histone Deacetylase Inhibitor SBHA with Proteasome Inhibitors Bortezomib or MG-132 on Breast Cancer Cells;
组蛋白去乙酰化酶抑制剂与蛋白酶体抑制剂协同抑制乳腺癌细胞及分子机制研究
12.
Purification and Anti-tumor Cell Invasiveness in Vitro of Cysteine Protease Inhibitor from Snake Venom;
蛇毒半胱氨酸蛋白酶抑制剂的分离及其抗肿瘤细胞体外侵袭特性
13.
Research Progress on Synthesis of Xylocydine--a Novel Inhibitor of Cyclin-Dependent Kinases;
细胞周期依赖性蛋白激酶(CDK)抑制剂Xylocydine合成研究进展
14.
Proteasome Inhibition by Bortezomib in the Regulation of NK Cell Survival and Function
蛋白酶体抑制剂对自然杀伤细胞活性和功能影响的研究
15.
Research Advances in Anticancer Cyclin-dependent-kinase Inhibitors
抗肿瘤细胞周期蛋白依赖性激酶抑制剂的研究进展
16.
Proteasome inhibitor MG-132 reverses acquired resistance to TRAIL in human colon cancer cells
蛋白酶体抑制剂MG-132逆转人结肠癌细胞获得性TRAIL耐药
17.
Study on the Inhibitory Action of HDACI on Choriocarcinoma Cell JAR Lines in Vitro
组蛋白去乙酰基酶抑制剂对绒癌JAR细胞的影响
18.
Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder transitional cell carcinoma;
基质金属蛋白酶及其抑制剂在膀胱移行细胞癌中的表达